"Important update: Medically accepted indication edit." Provider notice, June 2023
GLP-1s are not going anywhere pharma manufacturers continue to evolve their GLP-1/GIP product offerings (e.g., Eli Lillys Zepbound is the newest on the market), and the number of addressable indications is increasing (e.g., recent clinical evidence that may merit further FDA approval of GLP-1s for cardio-metabolic, nephrological and neurological indications)
Conclusion The best foods to eat on GLP-1 are those that deliver maximum nutritional value in manageable portions
Rare Disease Day Webinar: Voices that move systems Access the webinar replay offering actionable, cross-geography insights on how patient and caregiver voices can improve diagnosis, engagement, and outcomes
The FDA approved the first GLP-1 drug in 2005, and since then, the safety and efficacy of this medication type has only improved
Nutr Diabetes (2012) 2:e544